Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruifeng Wang

Showing results (211-220 of 242) with videos related to

Pageof 25
Sort By:
Clinical Immunology (Orlando, Fla.)|May 7, 2022
Imbalance of circulating innate lymphoid cell subpopulations in patients with chronic kidney diseaseRuifeng Wang, Jingjing Zhang, Dandan Li, et al.
Acta Pharmaceutica Sinica. B|April 12, 2019
Discovery of a series of dimethoxybenzene FGFR inhibitors with 5<i>H-</i>pyrrolo[2,3-<i>b</i>]pyrazine scaffold: structure-activity relationship, crystal structural characterization and <i>in vivo</i> studyPeng Wei, Bo Liu, Ruifeng Wang, et al.
Scientific Reports|April 26, 2017
Role of the virulence plasmid in acid resistance of Shigella flexneriChang Niu, Jing Yang, Hongsheng Liu, et al.
Acta Pharmaceutica Sinica. B|July 18, 2022
Engineered platelets-based drug delivery platform for targeted thrombolysisSongli Wang, Ruifeng Wang, Nana Meng, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 23, 2020
Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implicationsWei Liu, Paweł Stachura, Haifeng C Xu, et al.
Journal of Medicinal Chemistry|February 4, 2025
Discovery and Optimization of a Series of Novel Morpholine-Containing USP1 InhibitorsJunjie Zhang, Benjin Liu, Ruyue Ren, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 16, 2019
Non-immunogenic, low-toxicity and effective glioma targeting MTI-31 liposomesXiaoyi Wang, Nana Meng, Songli Wang, et al.
National Science Review|May 9, 2022
Direct observation of nodeless superconductivity and phonon modes in electron-doped copper oxide Sr<sub>1-x</sub>Nd<sub>x</sub>CuO<sub>2</sub>Jia-Qi Fan, Xue-Qing Yu, Fang-Jun Cheng, et al.
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
From Traditional Efficacy to Drug Design: A Review of Astragali RadixXiaojie Jin, Huijuan Zhang, Xiaorong Xie, et al.
Rheumatology (Oxford, England)|August 24, 2024
Serine protease inhibitor E2 protects against cartilage tissue destruction and inflammation in osteoarthritis by targeting NF-κB signallingLinzhu Wang, Shuangshuang Chen, Huizhen Zhang, et al.
Pageof 25

Showing results (211-220 of 242) with videos related to

Sort By:
Pageof 25
Clinical Immunology (Orlando, Fla.)|May 7, 2022
Imbalance of circulating innate lymphoid cell subpopulations in patients with chronic kidney diseaseRuifeng Wang, Jingjing Zhang, Dandan Li, et al.
Acta Pharmaceutica Sinica. B|April 12, 2019
Discovery of a series of dimethoxybenzene FGFR inhibitors with 5<i>H-</i>pyrrolo[2,3-<i>b</i>]pyrazine scaffold: structure-activity relationship, crystal structural characterization and <i>in vivo</i> studyPeng Wei, Bo Liu, Ruifeng Wang, et al.
Scientific Reports|April 26, 2017
Role of the virulence plasmid in acid resistance of Shigella flexneriChang Niu, Jing Yang, Hongsheng Liu, et al.
Acta Pharmaceutica Sinica. B|July 18, 2022
Engineered platelets-based drug delivery platform for targeted thrombolysisSongli Wang, Ruifeng Wang, Nana Meng, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 23, 2020
Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implicationsWei Liu, Paweł Stachura, Haifeng C Xu, et al.
Journal of Medicinal Chemistry|February 4, 2025
Discovery and Optimization of a Series of Novel Morpholine-Containing USP1 InhibitorsJunjie Zhang, Benjin Liu, Ruyue Ren, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 16, 2019
Non-immunogenic, low-toxicity and effective glioma targeting MTI-31 liposomesXiaoyi Wang, Nana Meng, Songli Wang, et al.
National Science Review|May 9, 2022
Direct observation of nodeless superconductivity and phonon modes in electron-doped copper oxide Sr<sub>1-x</sub>Nd<sub>x</sub>CuO<sub>2</sub>Jia-Qi Fan, Xue-Qing Yu, Fang-Jun Cheng, et al.
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
From Traditional Efficacy to Drug Design: A Review of Astragali RadixXiaojie Jin, Huijuan Zhang, Xiaorong Xie, et al.
Rheumatology (Oxford, England)|August 24, 2024
Serine protease inhibitor E2 protects against cartilage tissue destruction and inflammation in osteoarthritis by targeting NF-κB signallingLinzhu Wang, Shuangshuang Chen, Huizhen Zhang, et al.
Pageof 25